116 related articles for article (PubMed ID: 8273759)
21. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
[TBL] [Abstract][Full Text] [Related]
22. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
[TBL] [Abstract][Full Text] [Related]
23. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
24. Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm.
Sueda S; Kohno H
Intern Med; 2018 May; 57(10):1361-1369. PubMed ID: 29321418
[TBL] [Abstract][Full Text] [Related]
25. Implantable cardioverter-defibrillator: present and future indications.
Block M; Scheld H; Breithardt G
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
[TBL] [Abstract][Full Text] [Related]
26. Combined internal cardioverter-defibrillator implantation and myocardial revascularization for ischemic ventricular arrhythmias: optimal cost-effective strategy.
Lee JH; Folsom DL; Biblo LA; Carlson MD; Johnson NJ; Waldo AL; Geha AS
Cardiovasc Surg; 1995 Aug; 3(4):393-7. PubMed ID: 7582993
[TBL] [Abstract][Full Text] [Related]
27. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
[TBL] [Abstract][Full Text] [Related]
28. Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery disease.
Choue CW; Kim SG; Fisher JD; Roth JA; Ferrick KJ; Brodman R; Frame R; Gross J; Furman S
Am J Cardiol; 1994 Jun; 73(15):1075-9. PubMed ID: 8198033
[TBL] [Abstract][Full Text] [Related]
29. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
Klein H; Auricchio A; Reek S; Geller C
Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
[TBL] [Abstract][Full Text] [Related]
30. [10 years of therapy with implantable defibrillators--observation in 353 patients].
Trappe HJ; Wenzlaff P; Klein H; Pfitzner P; Fieguth HG; Kielblock B; Lichtlen PR
Z Kardiol; 1995 Mar; 84(3):222-31. PubMed ID: 7732715
[TBL] [Abstract][Full Text] [Related]
31. Implantation of a cardioverter-defibrillator after coronary artery bypass surgery.
Cernaianu AC; Cilley JH; Libby JA; Volosin R; DelRossi AJ
ASAIO J; 1992; 38(3):M257-60. PubMed ID: 1457860
[TBL] [Abstract][Full Text] [Related]
32. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
33. Survival of implantable cardioverter-defibrillator recipients: role of left ventricular function and its relationship to device use.
Mehta D; Saksena S; Krol RB
Am Heart J; 1992 Dec; 124(6):1608-14. PubMed ID: 1462921
[TBL] [Abstract][Full Text] [Related]
34. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG
Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252
[TBL] [Abstract][Full Text] [Related]
35. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
37. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
Silka MJ; Kron J; Dunnigan A; Dick M
Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
[TBL] [Abstract][Full Text] [Related]
38. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia.
Evonich RF; Maheshwari A; Gardiner JC; Khasnis A; Kantipudi S; Ip JH; Grimes D; Hayter G; Thakur RK
J Interv Card Electrophysiol; 2004 Aug; 11(1):59-65. PubMed ID: 15273456
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators.
Bhavnani SP; Kluger J; Coleman CI; White CM; Guertin D; Shafi NA; Yarlagadda RK; Clyne CA
Heart Rhythm; 2010 Jun; 7(6):755-60. PubMed ID: 20211275
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
